2024
DOI: 10.1007/s11883-024-01230-6
|View full text |Cite
|
Sign up to set email alerts
|

PCSK9 and Coronary Artery Plaque—New Opportunity or Red Herring?

Lucia Barbieri,
Gabriele Tumminello,
Isabella Fichtner
et al.

Abstract: Purpose of Review Although the clinical benefit of reducing low-density lipoprotein cholesterol (LDLc) in patients with coronary artery disease (CAD) is well-established, the impact on plaque composition and stability is less clear. Our narrative review aimed to assess the clinical effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on coronary plaque characteristics specifically focusing from atheroma progression to regression and stabilization. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 81 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?